Leukocyte-rich, poor PRP injections may have similar clinical improvements for knee OA

Published results showed intra-articular injections of leukocyte-rich platelet-rich plasma had similar clinical improvements as leukocyte-poor PRP injections in patients with symptomatic knee osteoarthritis.
Researchers randomly assigned 192 patients with symptomatic knee OA to receive three weekly injections of either leukocyte-rich PRP or leukocyte-poor PRP. Researchers evaluated IKDC subjective scores at baseline and at 2, 6 and 12 months, as well as KOOS subscales, EuroQol-VAS and Tegner scores.
Results showed the two groups had no differences in terms of absolute values or improvement in

Published results showed intra-articular injections of leukocyte-rich platelet-rich plasma had similar clinical improvements as leukocyte-poor PRP injections in patients with symptomatic knee osteoarthritis.
Researchers randomly assigned 192 patients with symptomatic knee OA to receive three weekly injections of either leukocyte-rich PRP or leukocyte-poor PRP. Researchers evaluated IKDC subjective scores at baseline and at 2, 6 and 12 months, as well as KOOS subscales, EuroQol-VAS and Tegner scores.
Results showed the two groups had no differences in terms of absolute values or improvement in